CapVest to Purchase Controlling Interest in Germany's Stada
Written by Emily J. Thompson, Senior Investment Analyst
Source: WSJ
Updated: Sep 01 2025
0mins
Source: WSJ
Acquisition Details
- Stake Acquisition: CapVest has agreed to acquire a majority stake in Stada, a German healthcare and pharmaceuticals company, from Bain Capital and Cinven.
- Financial Terms: The financial details of the transaction have not been disclosed.
Strategic Intent
- Development Goals: CapVest aims to accelerate Stada's growth both in its domestic market and internationally following the completion of the acquisition.
- Retention of Stake: Bain Capital and Cinven, who initially acquired Stada in 2017, will continue to hold a minority stake in the company post-transaction.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
